Modifying the physical characteristics of microscopic biomaterials to interact seamlessly with the body's tissues could ...
The waveLINE-010 trial will compare zilovertamab vedotin, in combination with rituximab plus cyclophosphamide, doxorubicin, and prednisone against the current standard-of-care in patients with ...
Amina Nurmammadova, an Azerbaijani PhD student at the MD Anderson Cancer Center Graduate School of Biomedical Sciences, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback